Overview

Pneumococcal Testing Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027.

There has been a substantial rise in the number of pneumococcal testing across the world with the current COVID-19 pandemic. Rising emphasis on molecular diagnostics for detecting respiratory pathogens has resulted in the pneumococcal testing market growth to a substantial level. Furthermore, this testing has gained clinical importance with respect to the ability of demonstrating high analytical specificity and sensitivity along with the capability of processing multiple respiratory specimens. The point of care testing is generally preferred as the conventional testing technique. This can be credited to the increased necessity to offer real-time results that aid the physicians to make correct decisions in the disease treatment. Furthermore, these tests are used for medical care has shifted focus on early detection, prevention and managing chronic conditions. 

Market Segmentation:

By Method 
•    Immunodiagnostics
•    Molecular Diagnostics 
•    Point of Care Testing
By Technology
•    Enzyme Linked Immunosorbent Assay   
•    Immunofluorescence
•    Western Blot
•    Polymerase Chain Reaction 
•    Immunohistochemistry
•    Others
By End User
•    Hospitals 
•    Homecare
•    Diagnostic Laboratories
•    Others
By Region 
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is categorised into method, technology, end user and region. The method segment is fragmented into immunodiagnostics, molecular diagnostics and point of care diagnostics. The point of care testing market held the largest pneumococcal testing market share during the forecast period as this method can test multiple samples at once which provides efficient workflow for healthcare organizations. The technology segment is bifurcated into enzyme linked immunohistochemistry, immunofluorescence, polymerase chain reaction, western block and others. The end user segment is classified into hospital, diagnostic laboratories, homecare and others. The hospital segment is anticipated to lead the market owing to a rise in the number of patients diagnosed with pneumococcal symptoms with the ongoing COVID-19 pandemic.

Regional Analysis:

The North America region is predicted to dominate the market during the forecast period owing to a strong presence of key market players in the region, growing investments for research and development in pneumococcal testing methodologies. The Asia Pacific region, on the other hand, is expected to lead the market owing to increased demand for these tests with the rising geriatric population in countries like Japan, China.

Competitive Landscape:                            

Some of the prominent players of the market are Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, Quidel.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global pneumococcal testing market by method, by technology, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
         1.1 Objectives of the Study 
         1.2 Market Definition 
         1.3 Market Scope 
                1.3.1 Years Considered for the Study
                1.3.2 Market Covered
         1.4 Currency
         1.5 Limitations 
         1.6 Stakeholders 
2. Research Methodology 
         2.1 Research Data 
              2.1.1 Secondary Data
                       2.1.1.1 Key Data from Secondary Sources
              2.1.2 Primary Data
                         2.1.2.1 Key Data from Primary Sources
         2.2 Market Size Estimation 
         2.3 Market Breakdown and Data Triangulation 
         2.4 Assumptions for the Study  
3. Executive Summary
         3.1 Market Outlook
         3.2 Segment Outlook
         3.3 Competitive Insights
4. Market Variables, Trends & Scope
         4.1 Market Lineage Outlook
         4.2 Penetration and Growth Prospect Mapping
         4.3 Industry Value Chain Analysis
         4.4 Cost Analysis Breakdown
         4.5 Technology Overview
         4.6 Regulatory Framework on Country Level
                4.6.1 Reimbursement Framework    
                4.6.2 Standards and Compliances
5. Market Overview
         5.1 Market Dynamics
               5.1.1 Market Driver Analysis
               5.1.2 Market Restraint Analysis
               5.1.3 Industry Challenges                   
6. Market Analysis tools                      
         6.1 Industry Analysis - Porter’s
                     6.1.1 Supplier Power
                     6.1.2 Buyer Power
                     6.1.3 Substitution Threat
                     6.1.4 Threat from new entrants
                     6.1.5 Competitive Rivalry                  
         6.2 Pestel Analysis
                     6.2.1 Political Landscape
                     6.2.2 Environmental Landscape
                     6.2.3 Social landscape
                     6.2.4 Technology landscape
                     6.2.5 Legal Landscape
7. Pneumococcal Testing Market, By Method Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         7.1 Immunodiagnostics
         7.2 Molecular Diagnostics 
         7.3 Point of Care Testing     
8. Pneumococcal Testing Market, By Technology Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         8.1 Enzyme Linked Immunosorbent Assay   
         8.2 Immunofluorescence
         8.3 Western Blot
         8.4 Polymerase Chain Reaction 
         8.5 Immunohistochemistry
         8.6 Others        
9. Pneumococcal Testing Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         9.1 Hospitals 
         9.2 Homecare
         9.3 Diagnostic Laboratories
         9.4 Others                           
10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         10.1. Introduction
         10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                10.2.1. U.S.
                10.2.2. Canada
                10.2.3. Mexico
                10.2.4 Rest of North America
         10.3 Market Size (USD Mn) Forecast for North America 2020-2027
11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         11.1. Introduction
         11.2. Regional Market Trends
         11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
               11.3.1. Brazil
                11.3.2. Uruguay
                11.3.3 Argentina
                11.3.4. Rest of Latin America
         11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          12.1. Introduction
          12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                12.2.1. Germany
                12.2.2. U.K
                12.2.3. France
                12.2.4. Italy
                12.2.5 Switzerland
                12.2.6. Spain
                12.2.7. Russia
                12.2.8. Poland
                12.2.9. Rest of Western Europe
          12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          13.1 Introduction
          13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 13.2.1 Japan
                 13.2.2 China
                 13.2.3 Singapore
                 13.2.4 Korea         
                 13.2.5 India
                 13.2.6 Australia and New Zealand
                 13.2.7 ASEAN
                 13.2.8 Rest of Asia Pacific
         13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          14.1 Introduction
          14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
          14.2.1 UAE
              14.2.2 South Africa
              14.2.3 Egypt
              14.2.4 Saudi Arabia
              14.2.5 Rest of MEA
          14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    15.1 Thermo Fisher Scientific Inc.
            15.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.1.2. Product Portfolio
            15.1.3. SWOT Analysis
            15.1.4. Financial Overview
            15.1.5. Strategic Overview
    15.2 Abbott Laboratories
            15.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.2. Product Portfolio
            15.2.3. SWOT Analysis
            15.2.4. Financial Overview
            15.2.5. Strategic Overview
    15.3 F-Hoffmann la Roche Ltd.
            15.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.2. Product Portfolio
            15.3.3. SWOT Analysis
            15.3.4. Financial Overview
            15.3.5. Strategic Overview
    15.4 Hologic Inc.
            15.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.4.2. Product Portfolio
            15.4.3. SWOT Analysis
            15.4.4. Financial Overview
            15.4.5. Strategic Overview
    15.5 bioMerieux
            15.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.5.2. Product Portfolio
            15.5.3. SWOT Analysis
            15.5.4. Financial Overview
            15.5.5. Strategic Overview
    15.6 Becton Dickenson and Company
            15.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.6.2. Product Portfolio
            15.6.3. SWOT Analysis
            15.6.4. Financial Overview
            15.6.5. Strategic Overview
    15.7 Bio-Rad Laboratories Inc.
            15.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.7.2. Product Portfolio
            15.7.3. SWOT Analysis
            15.7.4. Financial Overview
            15.7.5. Strategic Overview
    15.8 Meridian Biosciences
            15.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.8.2. Product Portfolio
            15.8.3. SWOT Analysis
            15.8.4. Financial Overview
            15.8.5. Strategic Overview    
    15.9 Quest Diagnostics
            15.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.9.2. Product Portfolio
            15.9.3. SWOT Analysis
            15.9.4. Financial Overview
            15.9.5. Strategic Overview
    15.10 Quidel
            15.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.10.2. Product Portfolio
            15.10.3. SWOT Analysis
            15.10.4. Financial Overview
            15.10.5. Strategic Overview
16 Impact of COVID-19
      16.1. Positive influence on the healthcare industry
      16.2. The financial disruption of the manufacturing sector
      16.3. Impact of COVID-19 on emerging companies
      16.4. Significant mandates in the healthcare regulations initiated by administrations
      16.5. The overall economic slowdown of the developing and developed nations
17. Competitive Intelligence and Competitive Matrix
      17.1 Competitive Intelligence
      17.2 Competitive Matrix
18. Major Deals and Strategic Alliances Analysis
      18.1 Joint ventures
      18.2 Mergers and acquisitions
      18.3 Licensing and partnerships 
      18.4 Technology Collaborations
      18.5 Strategic Divestments
      18.6 Market Entry Strategies                  
19. Relevant Case Studies and Latest News Updates    
20. Key Market Takeaway Points from the Market Analysts at Future Market Analytics

Tables

Figures